Jounce Therapeutics' Corporate Minority Round

Jounce Therapeutics raised a round of funding on July 19, 2016. Investors include Celgene.

Jounce Therapeutics is dedicated to transforming the treatment of cancer through discovering and developing novel cancer immunotherapies with the potential to drive significantly more durable response…

Articles about Jounce Therapeutics' Corporate Minority Round: